You also expressed concerns that PBMs, which are often vertically integrated with their own pharmacies, are using their pricing power to harm independent pharmacies.
If you have three companies making up the vast majority, that is not really competitive at all of an industry.
We want consumers to have choices, competition, and lower prescription drug prices.
By exempting the program from the normal process, politicians and bureaucrats can set prices that impact our healthcare in secret.
I get angry when I hear some politicians talk about the IRA's benefits and none of the downsides.
The Biden Administration should answer these questions, and this Committee should ask them.
All of the experts, all of them--CBO, the CMS actuary, and private academics--agree that the IRA will result in fewer therapies.
OMB is more than 2 years late in complying with a congressional mandate to give Federal agencies guidance on the acquisition and use of AI.
I would love to see efficiency at the VA. I hope you make good on that promise.
That inventory has been appropriately criticized in the press as being inconsistent and incomplete.
Two years late.